Stocktoria
Nuvalent, Inc. NUVL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-07-29
Chart by TradingView
1/9
Piotroski F — financial health
9.8
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Valuation · market cap as of 2026-06-29
Market cap$9.8B
P / B7.8×
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$414.3M | -$280.4M | -$149.5M | -$86.1M | -$45.8M |
| Net income | -$425.4M | -$260.8M | -$126.2M | -$81.9M | -$46.3M |
| Operating cash flow | -$275.2M | -$185.1M | -$99.7M | -$65.0M | -$40.0M |
| Total assets | $1.4B | $1.1B | $732.4M | $482.5M | $293.8M |
| Total liabilities | $164.4M | $72.0M | $31.8M | $19.5M | $8.8M |
| Shareholders' equity | $1.2B | $1.1B | $700.6M | $463.0M | $285.0M |
| Ratios | |||||
| Return on assets | -30.1% | -22.8% | -17.2% | -17.0% | -15.8% |
| Return on equity | -34.1% | -24.4% | -18.0% | -17.7% | -16.3% |
| Current ratio | 15.27 | 20.96 | 22.83 | 24.54 | 33.07 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 89,000 | $9.1M |
| Bridgewater Associates, LP | 15,020 | $1.5M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 9.8 (safe)
- Working capital / assets 0.921
- Retained earnings / assets -0.688
- EBIT / assets -0.293
- Equity / liabilities 7.595
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001861560 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.